China has taken the lead in CRISPR research as an oncology team in that country became the first to inject cells that contained edited genes using the technology.
The number of people with high blood pressure has almost doubled in 40 years to over 1.1 billion worldwide, scientists said, with the burden of the condition shifting from the rich to the poor.
Drinking colas and other sugary drinks is tied to an increased risk of so-called pre-diabetes – a precursor to full-blown disease – but diet soda is not, a recent study suggests.
A new type of heart drug developed by The Medicines Co. significantly lowered “bad” LDL cholesterol in high-risk patients with no major safety issues.
Amgen’s Repatha with statin therapy took “bad” LDL cholesterol down to extremely low levels and caused artery-clogging plaque decline after 18 months’ treatment.
This latest enhancement to the popular Family Finder test complements the myOrigins mapping tool which provides an ethnic and geographic breakdown of a where a person’s ancestors came from, and the updated Family Matching tool which allows users to sort confirmed DNA matches by paternal and maternal lines.
uniQure NV recently completed a strategic review with a decision to refocus its pipeline and cut 20 to 25 percent of its workforce.
It’s been 10 years since the Amgen Scholars Program was put into place, with more than 3,000 students participating. After a decade, the foundation has tagged 10 participants for its Ten to Watch list who are likely to play big roles in the science and medical industries.
Puma Biotechnology shares plummeted after the company disclosed patients taking its experimental breast cancer drug neratinib may require a second drug to prevent serious diarrhea.
Roche has launched a global cancer immunotherapy Centers of Research Excellence network, saying it will invest up to 100 million Swiss francs ($100.3 million) in the project.